Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.05 ($40,490)
  4. 4 Exercise or conversion Chief Executive Officer acquired 20,000 shares (option exercise)
  5. 4 Open-market buy Director bought 5,000 shares at $4.17 ($20,850)
  6. 4 Open-market buy Director bought 6,250 shares at $3.98 ($24,850)
  7. 4 Open-market buy Director bought 10,000 shares at $4.12 ($41,200)
  8. 4 Open-market buy Chief Financial Officer bought 5,000 shares at an average $4.68 ($23,379)
  9. 5 Insider Annual Insider Trading Report
  10. 5 Insider Annual Insider Trading Report
  11. 5 Insider Annual Insider Trading Report
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $4.17 ($8,340)
  14. 4 Exercise or conversion Vice President & Secretary acquired 80,000 shares (option exercise)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 19 of 37 · 722 filings